Expo Hub
Cancer Care Pathway
Follow Lisa and Tom on their journeys
1https://www.who.int/news-room/fact-sheets/detail/cancer
2https://jamanetwork.com/journals/jamaoncology/fullarticle/2801798
3https://gco.iarc.fr/tomorrow/en/dataviz/isotype?years=2050
4https://www.axios.com/2022/12/15/cancers-screening-tests-research
5https://www.acr.org/news-and-publications/acr-rbma-urge-congress-to-address-workforce-shortages
6Lauritzen AD, Lillholm M, Lynge E, Nielsen M, Karssemeijer N, Vejborg I. Early Indicators of the Impact of Using AI in Mammography Screening for Breast Cancer. Radiology. 2024 Jun;311(3):e232479
7Courtesy of Diagnostikum Linz, Linz, Austria
8Maldera et al. (2016): Digital breast tomosynthesis: Dose and image quality assessment. Physica Medica, pp. 1-12
9Data on file. For average breast size of 50/50 glandular/adipose tissue and 5 cm thickness’
10Courtesy of Central Alabama Radiation Oncology, Montgomery, USA
The concepts and information presented in this video are based on research results that are not commercially available. Future availability cannot be guaranteed.
The concepts and information presented in this video are based on research results that are not commercially available. Future availability cannot be guaranteed.
11https://pmc.ncbi.nlm.nih.gov/articles/PMC10388018/?utm_source=chatgpt.com
12Statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no typical hospital and many
variables exist (e.g hospital size, case mix) there can be no guarantee that other customers will achieve the same results.
variables exist (e.g hospital size, case mix) there can be no guarantee that other customers will achieve the same results.
13Deep Resolve for VIBE is pending 510(k) clearance and are not yet commercially available in the U.S.A. It’s future availability cannot be guaranteed.
14MAGNETOM Free.XL. is under development. Its future availability cannot be guaranteed.
15AI-Rad Companion Prostate MR is not commercially available in all countries, and its future availability cannot be ensured.
16Courtesy of Esser M, Zinsser D, Kündel M, et al. Performance of an Automated Workflow for Magnetic Resonance
Imaging of the Prostate: Courtesy ofComparison With a Manual Workflow. Invest Radiol. 2019 Dec 30. Benson Radiology, City West, Australia.
17EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. Sangro, Bruno et al. Journal of Hepatology, Volume 82, Issue 2, 315 – 374.
18Global Interventional Oncology Ablation Market Size By Technology Segment. Interventional Oncology Ablation Market report. Verified Market Reports. February 2025, Report ID469812.
19Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: a population-based study. Zhu, Hongcheng et al. The Lancet Global Health, Volume 12, Issue 12, e1945 - e1953.
20Courtesy of Bernhard Meyer, MD, Hannover Medical School, Germany
21Multiple studies, e.g. Joo, I., Morrow, K. W., Raman, S. S., McWilliams, J. P., Sayre, J. W., & Lu, D. S. (2022). CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control. European Radiology. https://doi.org/10.1007/s00330-022-08723-5
Laimer, G., Jaschke, N., Schullian, P., Putzer, D., Eberle, G., Solbiati, L., Solbiati, L., Goldberg, S. N., & Bale, R. (2021). Volumetric assessment of the periablation safety margin after thermal ablation of colorectal liver metastases. European Radiology. https://doi.org/10.1007/s00330-020-07579-x
22https://www.varian.com/products/interventional-solutions/microwave-solutions/intelliblate
23The products / features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
24Courtesy of Nordstrahl, Praxis für Strahlentherapie, Nürnberg, Germany
25Courtesy of Universitätsklinikum Erlangen, Germany
26Courtesy of Radiologische Allianz Hamburg, Germany, Rendering is based on research results that are not commercially available.
27Courtesy of Acibadem Atasehir Hospital, Instanbul, Turkey
28Needles are concept device – not approved for commercial sale or clinical use.
The information shown herein refers to products of 3rd party manufacturer’s and thus are in their regulatory responsibility. Please contact the 3rd party manufacturer for further information.
The information shown herein refers to products of 3rd party manufacturer’s and thus are in their regulatory responsibility. Please contact the 3rd party manufacturer for further information.